- Previous Close
1.4100 - Open
1.5100 - Bid 1.4500 x 800
- Ask 1.5300 x 500
- Day's Range
1.2700 - 1.6400 - 52 Week Range
1.1500 - 6.4800 - Volume
5,796,624 - Avg. Volume
784,566 - Market Cap (intraday)
50.804M - Beta (5Y Monthly) 3.98
- PE Ratio (TTM)
-- - EPS (TTM)
-4.6100 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.17
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
www.inotiv.com1,977
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: NOTV
View More
Performance Overview: NOTV
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NOTV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NOTV
View MoreValuation Measures
Market Cap
50.80M
Enterprise Value
459.87M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.08
Price/Book (mrq)
0.30
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-25.40%
Return on Assets (ttm)
-4.78%
Return on Equity (ttm)
-56.93%
Revenue (ttm)
475.11M
Net Income Avi to Common (ttm)
-120.69M
Diluted EPS (ttm)
-4.6100
Balance Sheet and Cash Flow
Total Cash (mrq)
38.04M
Total Debt/Equity (mrq)
263.27%
Levered Free Cash Flow (ttm)
19.3M
Research Analysis: NOTV
View MoreResearch Reports: NOTV
View MoreDaily – Vickers Top Buyers & Sellers for 12/13/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 12/11/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 12/18/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 02/27/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.